Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Up 157.9% in March

Heart Test Laboratories, Inc. (NASDAQ:HSCS) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 506,000 shares, a growth of 157.9% from the February 29th total of 196,200 shares. Based on an average daily trading volume, of 2,900,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 1.0% of the shares of the company are short sold.

Heart Test Laboratories Price Performance

HSCS stock remained flat at $0.12 during mid-day trading on Friday. The company’s stock had a trading volume of 1,482,600 shares, compared to its average volume of 2,002,157. Heart Test Laboratories has a 12 month low of $0.11 and a 12 month high of $1.49. The business has a 50 day moving average price of $0.13 and a 200-day moving average price of $0.22. The firm has a market capitalization of $7.66 million, a PE ratio of -0.24 and a beta of 3.44.

Institutional Investors Weigh In On Heart Test Laboratories

A number of hedge funds and other institutional investors have recently modified their holdings of HSCS. Virtu Financial LLC raised its stake in shares of Heart Test Laboratories by 896.8% during the fourth quarter. Virtu Financial LLC now owns 255,382 shares of the company’s stock valued at $44,000 after purchasing an additional 229,762 shares in the last quarter. Vanguard Group Inc. bought a new stake in Heart Test Laboratories in the fourth quarter worth about $30,000. Astoria Strategic Wealth Inc. lifted its holdings in Heart Test Laboratories by 246.1% in the 3rd quarter. Astoria Strategic Wealth Inc. now owns 81,995 shares of the company’s stock valued at $35,000 after acquiring an additional 58,303 shares during the last quarter. Jane Street Group LLC acquired a new stake in Heart Test Laboratories in the 2nd quarter valued at about $28,000. Finally, Renaissance Technologies LLC lifted its holdings in Heart Test Laboratories by 55.7% in the 2nd quarter. Renaissance Technologies LLC now owns 35,350 shares of the company’s stock valued at $32,000 after acquiring an additional 12,650 shares during the last quarter. 17.24% of the stock is currently owned by institutional investors.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.